This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_RECTUM_MUCINO_EXALLC for full statistics.
Mucinous and mucinous cystic tumor of rectum
C3_RECTUM_MUCINO
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
149 |
4. Check minimum number of eventsNone |
149 |
5. Include endpointsNone |
149 |
6. Filter based on genotype QC (FinnGen only) |
149 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Mucinous and mucinous cystic tumor of rectum
based on the number of shared cases.
Similar with more cases:
- Mucinous and mucinous cystic tumor of rectum, excluding all cancers (controls excluding all cancers)
- Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum
- Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)
- Colorectal cancer
- Colorectal cancer, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 149 | 49 | 100 |
| Unadjusted period prevalence (%) | 0.04 | 0.02 | 0.04 |
| Median age at first event (years) | 68.42 | 67.31 | 68.96 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 137
- Matched controls
- 1368
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
8480/3-C20.9
ICD-O-3
Mucinous adenocarcinoma of rectum, NOS
+∞
146.3
113
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
514.0
136.0
119
17
L01BC06
ATC
capecitabine; oral
85.2
73.5
80
22
130
Kela drug reimbursment
Malignant tumour
39.7
70.3
98
81
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
170.7
70.1
69
8
UJF32
NOMESCO Finland
Coloscopy
14.9
43.8
104
239
A03FA01
ATC
metoclopramide; systemic, rectal
13.2
39.7
88
164
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
18.9
39.4
65
62
C20
ICD-10 Finland
Malignant neoplasm of rectum
173.4
37.9
38
*
WF001
NOMESCO Finland
Preoperative radiotherapy
103.8
36.0
38
5
WX302
NOMESCO Finland
Thoracal epidural anesthesy
18.7
29.6
47
37
JN4BD
NOMESCO Finland
Extensive body CT
9.7
25.9
60
102
A04AA02
ATC
granisetron; systemic, transdermal
15.7
25.9
44
40
8480/3-C19.9
ICD-O-3
Mucinous adenocarcinoma of rectosigmoid junction
+∞
25.8
24
*
H02AB02
ATC
dexamethasone; systemic
10.6
24.2
51
72
C20.99
ICD-10 Finland
Malignant tumor of the rectum other or unspecified histology
75.6
22.7
25
*
JFF23
NOMESCO Finland
Transversostomy
45.3
21.7
26
7
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
14.8
21.1
36
32
JG1BG
NOMESCO Finland
MRI of rectum
86.4
20.3
22
*
JGB06
NOMESCO Finland
Partial proctectomy with total excision of mesorectum
86.4
20.3
22
*
C20.92
ICD-10 Finland
Malignant tumor of the rectum carcinoma of the adenoma
86.4
20.3
22
*
B01AB05
ATC
enoxaparin; parenteral
5.4
19.2
83
302
JFG10
NOMESCO Finland
Closure of loop colostomy without resection
31.9
18.5
24
9
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
20.6
18.3
27
16
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
25.1
18.1
25
12
C19
ICD-10 Finland
Malignant neoplasm of rectosigmoid junction
49.1
17.9
21
5
D37.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Rectum
58.0
17.5
20
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
16.5
16.9
27
20
WX408
NOMESCO Finland
General anesthesy, balanced
4.8
16.2
73
263
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
23.5
15.7
22
11
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
9.1
15.6
34
48
TJF80
NOMESCO Finland
Ostomy education
48.1
14.5
17
*
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
16.0
14.3
23
17
D75
ICPC
Malignant neoplasm colon/rectum
59.8
14.1
16
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
4.2
14.0
75
307
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
12.5
13.9
25
24
WZC30
NOMESCO Finland
Teaching
5.2
13.9
49
132
JG1CG
NOMESCO Finland
Extensive MRI of rectum
83.3
13.9
15
*
JGB07
NOMESCO Finland
Laparoscopic partial proctectomy with total excision of mesorectum
83.3
13.9
15
*
B01AB10
ATC
tinzaparin; parenteral
8.8
13.7
30
42
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
13.0
13.7
24
22
TPH07
NOMESCO Finland
Cathetrisation of artery
6.1
13.7
40
86
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
17.7
13.1
20
13
JFG20
NOMESCO Finland
Closure of enterostomy with resection of exteriorised loop
41.7
12.5
15
*
JFG00
NOMESCO Finland
Closure of loop enterostomy without resection
51.5
12.1
14
*
ZXE20
NOMESCO Finland
More than three and less than five hours
5.1
12.1
42
109
SPAT1125
SPAT
Stoma care and guidance
22.4
11.4
16
8
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
9.3
11.1
23
29
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
30.9
11.0
14
5
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
7.6
10.6
25
39
JGB00
NOMESCO Finland
Partial proctectomy and colorectal or coloanal anastomosis
35.6
10.5
13
*
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
59.3
9.8
11
*
JGB03
NOMESCO Finland
Partial proctectomy with partial excision of mesorectum
+∞
9.5
9
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
4.9
9.4
32
80
XX3DW
NOMESCO Finland
Time consuming IT work
4.6
9.4
34
91
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
39.5
9.2
11
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
26.1
9.1
12
5
Z93.3
ICD-10 Finland
Colostomy status
26.1
9.1
12
5
JGB30
NOMESCO Finland
Abdominoperineal excision of rectum
53.5
8.8
10
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
17.8
8.7
13
8
JN4CD
NOMESCO Finland
Very extensive body CT
7.4
8.6
20
31
JGB31
NOMESCO Finland
Laparoscopic and perineal excision of rectum
95.6
8.5
9
*
JN4AD
NOMESCO Finland
Body CT examination
4.8
8.4
29
73
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
6.9
8.2
20
33
N02AA05
ATC
oxycodone; systemic
3.6
8.0
39
136
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.5
7.9
23
48
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
12.9
7.8
13
11
Y88
ICD-10 Finland
Sequelae with surgical and medical care as external cause
26.7
7.7
10
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
16.9
7.4
11
7
SPAT1262
SPAT
Handing over of treatment supplies
3.1
6.9
44
183
JFF10
NOMESCO Finland
Loop enterostomy
23.9
6.8
9
*
JAH00
NOMESCO Finland
Laparotomy
10.8
6.7
12
12
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
10.8
6.7
12
12
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.0
6.6
26
75
JGB36
NOMESCO Finland
Wide excision of rectum
73.1
6.5
7
*
ZX120
NOMESCO Finland
Intravenous
4.1
6.5
25
71
ZXC96
NOMESCO Finland
Robot assisted procedure
7.7
6.4
14
20
Z51.5
ICD-10 Finland
Palliative care
4.9
6.4
20
46
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
19.1
6.3
9
5
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
19.1
6.3
9
5
N02BE01
ATC
paracetamol; systemic, rectal
3.5
6.3
122
955
JGB04
NOMESCO Finland
Laparoscopic partial proctectomy with partial excision of mesorectum
28.1
6.3
8
*
L01XE21
ATC
[U] regorafenib; oral
+∞
6.3
6
*
3018
Kela drug reimbursment
The combination of trifluridine and tipiracil
+∞
6.3
6
*
L01BC59
ATC
trifluridine, combinations; systemic
+∞
6.3
6
*
1506
Kela drug reimbursment
The combination of trifluridine and tipiracil
+∞
6.3
6
*
WW500
NOMESCO Finland
Blood transfusion
7.3
6.2
14
21
D18
ICPC
Change in faeces/bowel movements
9.3
6.2
12
14
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
13.3
6.2
10
8
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
121
150
38.60
108.20
11.9
4.9
ug/l
14.5
33.8
0.31
112
126
(3022145) Colonoscopy Study observation
61
155
5.97
24.51
1.6
1.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
104
573
3.70
12.61
7.5
4.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
97
546
3.23
10.67
16.0
8.7
inr
1.3
1.3
0.11
26
152
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
40
136
3.65
10.16
3.5
2.3
umol/l
9.3
9.1
0.02
32
117
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
32
93
4.11
10.15
1.9
1.5
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
75
399
2.77
8.58
5.8
4.1
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
108
703
2.95
8.19
23.1
10.2
e9/l
3.8
4.3
1.38
98
618
(3014576) Chloride [Moles/volume] in Serum or Plasma
43
180
2.95
7.59
12.8
6.7
mmol/l
104.3
103.6
0.47
43
175
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
18
44
4.52
7.04
1.9
2.0
u/ml
0.2
0.4
1.37
11
24
(3026008) Bacteria identified in Urine by Culture
68
375
2.50
6.86
3.9
3.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
72
420
2.38
6.28
3.4
2.4
—
—
—
0
0
(4035726)
33
132
2.93
6.24
1.7
1.4
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
45
224
2.45
5.48
3.7
3.4
mmol/l
0.8
0.8
0.83
45
211
(3019060) Gas panel - Arterial blood
26
100
2.94
5.23
8.5
4.3
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
36
168
2.51
4.99
11.2
7.3
mmol/l
1.7
1.2
0.33
29
135
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
14
37
4.07
4.94
1.6
1.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
55
312
2.21
4.88
2.9
2.4
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
91
630
2.14
4.81
8.1
7.4
mmol/l
1.2
1.2
1.74
72
533
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
20
72
3.05
4.49
13.9
8.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
51
291
2.14
4.39
1.4
1.3
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
36
178
2.35
4.37
3.5
5.9
mmol/l
1.0
1.0
0.35
36
165
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
26
110
2.65
4.37
2.7
1.9
u/l
27.2
36.8
0.73
26
89
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
11
28
4.16
4.05
1.9
1.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
72
485
1.94
3.81
2.7
2.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
8
14
5.97
3.39
1.4
2.0
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
37
206
2.06
3.31
1.8
1.9
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
8
15
5.57
3.23
1.4
1.9
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
8
15
5.57
3.23
1.4
1.9
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
8
15
5.57
3.23
1.4
1.9
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
8
16
5.22
3.09
1.4
1.9
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
8
16
5.22
3.09
1.4
1.9
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
36
204
2.01
3.05
3.1
2.0
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
17
70
2.61
3.00
2.1
1.9
ug/l
1.0
5.2
0.55
17
64
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
79
579
1.78
2.98
7.9
6.1
mmol/l
1.2
1.2
1.60
70
526
(3031040) Bacteria [#/volume] in Urine by Automated count
100
786
1.83
2.97
6.5
4.3
e6/l
794.4
53.0
—
5
15
(3002256) Pathology report gross observation
28
147
2.11
2.90
1.3
1.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
26
141
2.02
2.47
3.5
3.9
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
101
824
1.70
2.35
7.0
4.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
12
47
2.69
2.33
1.2
2.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
38
240
1.78
2.29
3.8
3.5
ng/l
544.5
181.3
0.34
27
203
(3033658) Prothrombin time (PT) actual/Normal
47
318
1.70
2.23
5.9
3.6
%
76.7
86.5
1.36
47
311
(3000850) Epithelial cells [#/volume] in Urine
42
278
1.71
2.15
3.0
2.6
e6/l
11.9
3.7
0.61
35
241
(3007853) Bacteria identified in Skin by Aerobe culture
26
149
1.90
2.12
1.6
1.7
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
74
571
1.59
2.05
6.1
6.0
%
63.6
58.3
2.70
68
536
(3002030) Lymphocytes/100 leukocytes in Blood
75
581
1.59
2.04
6.0
6.3
%
21.0
26.1
3.41
68
540
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
14
64
2.31
2.01
2.1
2.5
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
9
33
2.84
1.97
2.4
3.2
umol/l
37.7
31.8
—
9
27
(3006184) Hemoglobin [Mass/volume] in Capillary blood
9
33
2.84
1.97
2.2
2.6
g/l
109.0
125.5
—
9
23
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
101
1150
0.62
1.87
4.8
4.9
mmol/l
1.3
1.4
1.88
96
1036
(3022096) Basophils/100 leukocytes in Blood
71
552
1.55
1.85
5.6
6.0
%
0.5
0.6
1.89
64
514
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
10
41
2.54
1.79
1.1
1.8
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
72
567
1.52
1.74
5.8
6.0
%
2.3
2.7
1.18
66
528
(3019069) Monocytes/100 leukocytes in Blood
72
571
1.50
1.66
5.9
6.4
%
9.2
8.9
0.20
66
536
(3012544) pH of Venous blood
22
130
1.81
1.64
2.5
4.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
106
1183
0.64
1.60
5.1
5.6
mmol/l
2.7
2.6
0.21
95
1067
(40768797) Stomach Pathology biopsy report
8
169
0.44
1.59
1.4
1.2
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
20
116
1.84
1.58
9.4
7.0
mmol/l
1.5
1.3
0.55
20
111
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
103
1155
0.65
1.57
4.8
4.9
mmol/l
4.5
4.5
0.04
97
1050
(3000991) Gas panel - Venous blood
19
110
1.83
1.51
9.3
8.4
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
76
623
1.45
1.42
5.4
6.0
e9/l
1.4
1.8
3.73
67
553
(3018677) aPTT in Platelet poor plasma by Coagulation assay
32
219
1.59
1.42
2.0
1.8
s
30.9
30.1
0.24
32
212
(3002582) Erythrocytes [#/volume] in Urine
53
406
1.47
1.41
3.5
3.1
e6/l
16.7
219.5
0.69
44
312
(3022621) pH of Urine by Test strip
13
68
2.00
1.38
3.7
1.9
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
5
17
3.01
1.37
1.6
1.6
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
71
843
0.70
1.35
3.5
3.7
pmol/l
14.8
15.1
0.63
62
736
(3021601) Nitrite [Presence] in Urine by Test strip
73
601
1.42
1.30
6.3
5.0
estimate
0.0
0.0
0.00
15
121
(3026389) Candida sp identified in Specimen by Organism specific culture
5
18
2.84
1.29
1.0
1.2
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
76
633
1.41
1.26
5.8
6.1
e9/l
0.1
0.2
4.65
67
560
(3041096) Erythrocytes [Presence] in Urine by Automated
45
341
1.46
1.25
5.2
3.6
—
—
—
0
0
(3026782) Osmolality of Urine
37
270
1.49
1.23
2.5
3.1
mosm/kgh2o
514.5
579.9
1.09
29
231
(3002032) Base excess in Venous blood by calculation
20
126
1.68
1.22
2.6
4.3
mmol/l
1.4
1.9
0.27
14
98
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
0
33
0.00
1.17
0.0
1.2
—
2.1
—
0
6
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
0
34
0.00
1.17
0.0
1.2
—
2.0
—
0
8
(3035350) Ketones [Presence] in Urine by Test strip
72
600
1.39
1.16
5.0
3.7
estimate
0.0
0.0
0.00
15
122
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
18
113
1.67
1.12
2.8
4.6
mmol/l
1.2
1.2
0.16
13
103
(3021901) Oxygen saturation in Capillary blood
7
32
2.24
1.09
3.0
2.8
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
59
480
1.38
1.08
3.6
3.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
5
107
0.45
1.06
1.2
2.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
72
607
1.36
1.05
5.0
3.7
estimate
0.0
0.0
0.00
13
116
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
97
1074
0.72
1.05
4.4
4.5
mu/l
2.1
2.0
0.43
89
937
(3006315) Basophils [#/volume] in Blood
73
617
1.36
1.05
5.3
5.9
e9/l
0.0
0.0
1.24
62
532
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
58
476
1.36
1.00
5.7
4.0
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
0
29
0.00
0.99
0.0
1.1
—
14.6
—
0
23
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
30
0.00
0.98
0.0
1.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
22
151
1.54
0.97
2.1
1.8
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
72
614
1.33
0.95
5.0
5.9
e9/l
0.6
0.6
0.16
63
527
(3013512) EKG study
51
413
1.36
0.95
3.9
4.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
9
154
0.56
0.95
33.1
8.7
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
7
127
0.53
0.93
1.1
2.8
g/l
64.5
66.5
—
7
117
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
22
153
1.51
0.92
2.1
1.8
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
66
558
1.33
0.92
16.8
11.0
e9/l
0.0
0.0
0.09
57
456
(36304419) Bacteria [Presence] in Urine
44
351
1.36
0.90
3.1
2.9
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
6
31
1.97
0.85
5.5
4.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
11
65
1.75
0.85
1.3
1.3
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
13
81
1.66
0.84
12.8
8.6
mmol/l
24.8
24.6
0.10
13
75
(3018418) pH of Serum or Plasma
48
392
1.33
0.84
4.1
4.3
ph
7.4
7.4
0.26
12
82
(3008898) HLA-B27 [Presence]
0
24
0.00
0.80
0.0
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
0
25
0.00
0.80
0.0
1.3
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
9
53
1.74
0.77
1.1
1.1
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
55
463
1.30
0.77
3.9
3.6
e6/l
45.6
60.0
0.36
46
328
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
124
1163
1.39
0.76
37.4
16.6
mg/l
42.1
26.5
4.14
118
946
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
7
39
1.83
0.73
1.6
1.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
16
110
1.51
0.72
4.3
4.1
—
—
—
0
0
(3020891) Body temperature
9
58
1.59
0.71
10.0
4.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
7
44
1.62
0.66
3.7
5.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
32
255
1.32
0.65
4.0
5.7
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
49
415
1.27
0.64
5.2
5.7
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
0
20
0.00
0.61
0.0
1.2
—
331.3
—
0
10
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
0
20
0.00
0.61
0.0
1.3
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
20
0.00
0.61
0.0
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
21
0.00
0.60
0.0
1.6
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
10
64
1.60
0.60
3.1
4.3
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
6
35
1.74
0.58
1.2
1.5
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
11
73
1.55
0.58
4.3
3.6
e6/l
1.5
0.2
0.92
11
73
(4010399)
6
97
0.60
0.54
1.0
1.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
38
319
1.26
0.53
20.6
6.9
—
—
—
0
0
(3019225) pH of Specimen
16
118
1.40
0.53
2.2
4.3
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
25
199
1.31
0.52
1.6
2.4
%
19.2
23.3
0.81
20
177
(3044889) 12 lead EKG panel
94
870
1.22
0.51
4.7
4.3
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
40
340
1.24
0.50
6.4
4.0
estimate
0.0
0.0
0.00
12
113
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
32
381
0.80
0.50
2.3
3.1
ug/l
0.7
0.8
0.04
21
274
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
7
45
1.58
0.49
1.3
1.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
7
50
1.42
0.45
1.0
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
5
33
1.53
0.41
1.0
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
5
33
1.53
0.41
1.0
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
5
33
1.53
0.41
2.0
1.6
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
5
33
1.53
0.41
1.0
1.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
0
15
0.00
0.41
0.0
1.8
—
540.4
—
0
8
(21494890) Protein electrophoresis panel - 24 hour Urine
0
16
0.00
0.41
0.0
3.2
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
0
16
0.00
0.41
0.0
1.1
—
7.3
—
0
8
(3016650) Hepatitis A virus Ab [Presence] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(4062490)
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
0
18
0.00
0.40
0.0
1.5
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
23
189
1.26
0.39
15.9
23.9
inr
1.4
1.3
—
7
22
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
59
537
1.16
0.36
3.9
4.3
ng/l
21.0
45.0
2.60
42
411
(3030467) Casts [#/volume] in Urine by Automated count
42
372
1.18
0.35
3.4
3.0
e6/l
0.5
0.5
0.01
31
275
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
47
522
0.85
0.35
3.9
4.8
%
19.6
21.4
0.36
22
278
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
6
45
1.35
0.34
1.3
1.6
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
10
75
1.36
0.31
1.6
1.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
8
109
0.72
0.30
4.3
3.3
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
12
95
1.29
0.27
4.1
3.7
kpa
4.9
5.0
0.24
12
90
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
43
472
0.87
0.27
2.1
2.3
nmol/l
68.1
77.8
1.42
37
410
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
5
74
0.66
0.26
1.0
1.3
—
25.1
—
0
9
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
7
93
0.74
0.23
1.7
1.3
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
58
542
1.11
0.22
2.1
2.0
pmol/l
81.7
93.4
1.02
40
280
(3017181) Myelocytes/100 leukocytes in Blood
13
107
1.24
0.22
6.5
4.7
%
1.9
1.1
—
5
38
(3004716) Salmonella sp identified in Stool by Organism specific culture
5
41
1.23
0.22
1.0
1.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
47
435
1.12
0.21
2.7
3.3
ng/l
1699.3
1314.4
0.38
41
362
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
2.0
—
—
—
0
0
(3035880) pH of Pleural fluid
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
0
10
0.00
0.21
0.0
2.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
2.3
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.5
—
4.7
—
0
13
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3000492) Spirometry study
12
99
1.23
0.20
1.4
1.4
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
29
261
1.14
0.20
1.8
1.7
nmol/l
994.7
1225.0
0.85
24
200
(3019150) Specific gravity of Urine by Refractometry
28
252
1.14
0.19
7.8
4.1
kg/l
1.0
1.0
—
6
33
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
7
60
1.17
0.18
1.9
1.6
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
25
276
0.89
0.17
4.9
3.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
12
104
1.17
0.13
1.0
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
10
115
0.86
0.11
1.1
1.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
6
54
1.12
0.09
1.3
3.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
25
234
1.08
0.09
1.0
1.2
u/ml
1.9
0.8
—
6
69
(3012516) Albumin [Mass/volume] in Urine
39
408
0.94
0.08
2.9
3.3
mg/l
51.1
202.8
0.51
30
276
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
115
1133
1.07
0.08
33.8
15.9
ml/min/173m2
79.6
75.4
1.66
102
924
(3022313) Gas panel - Capillary blood
7
67
1.05
0.08
4.6
3.8
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
7
67
1.05
0.08
1.0
1.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
8
73
1.10
0.07
1.0
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
36
376
0.94
0.07
3.8
3.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
9
84
1.08
0.07
1.6
1.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
54
557
0.95
0.07
2.2
2.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
42
435
0.95
0.06
3.6
4.2
mg/mmol
5.4
7.8
0.42
29
284
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
64
654
0.96
0.05
3.6
5.2
ug/l
2.6
2.6
0.02
53
583
(3017143) Hepatitis C virus Ab [Presence] in Serum
11
102
1.08
0.03
1.0
1.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
13
122
1.07
0.03
1.2
1.5
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
126
1252
1.04
0.02
46.7
20.0
umol/l
79.0
83.4
1.15
126
1252
(40761511) CBC panel - Blood by Automated count
121
1217
0.97
0.01
38.3
15.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
11
114
0.96
0.00
1.3
1.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
17
166
1.03
0.00
3.0
1.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
22
216
1.02
0.00
3.2
2.6
e6/l
0.4
1.1
1.29
14
122
(3007164) IgA [Mass/volume] in Serum or Plasma
22
219
1.01
0.00
1.1
1.3
g/l
2.5
2.5
0.00
15
127
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
16
158
1.01
0.00
1.3
1.3
u/ml
0.9
11.0
—
8
58
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
20
202
0.99
0.00
3.4
2.8
e6/l
0.3
2.3
2.03
12
111
(3009542) Hematocrit [Volume Fraction] of Blood
100
1004
0.99
0.00
37.7
17.1
%
36.9
39.3
1.12
58
663
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
5
54
0.92
0.00
5.4
3.6
pmol/l
4.6
4.3
—
5
49
(21491868) Cryoglobulin [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000012) Reticulocyte production index
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
7
71
0.99
0.00
1.1
1.2
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
226.8
—
0
9
(44806420)
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
8
0.00
0.00
0.0
13.6
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.5
—
16.3
—
0
6
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
41.0
—
0
5
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
11.4
—
0
7
(3024263) Appearance of Synovial fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.3
—
14.1
—
0
8
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
5
0.00
0.00
0.0
1.2
—
10.4
—
0
5
(3037556) Urate [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
23.7
—
0
6
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
6
65
0.92
0.00
1.8
3.9
mmol/l
23.8
24.1
—
6
58
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
54.0
—
0
5
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
7
0.00
0.00
0.0
1.1
—
137.0
—
0
7
(40765096) Chromosome analysis panel by Banding
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
27.2
—
0
6
(3049717) Cytology report of Urine Cyto stain
5
57
0.87
0.00
3.0
3.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768443) Skin Pathology biopsy report
5
50
1.00
0.00
1.2
1.3
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_RECTUM_MUCINO – Mucinous and mucinous cystic tumor of rectum
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).